Evaluation of dose received by organs at risk in radiotherapy of brain tumors

被引:0
|
作者
Farzin, M. [1 ,2 ]
Haddad, P. [1 ]
Rajabpour, M. Vand [1 ,3 ]
Gorjizadeh, N. [4 ]
Babaloui, S. [5 ]
机构
[1] Univ Tehran Med Sci, Inst Canc, Radiat Oncol Res Ctr RORC, Tehran, Iran
[2] Univ Tehran Med Sci, Neurosci Inst, Brain & Spinal Cord Injury Res Ctr, Tehran, Iran
[3] Univ Tehran Med Sci, Canc Inst Iran, Canc Res Ctr, Tehran, Iran
[4] Univ Tehran Med Sci, Inst Canc, Dept Radiat Phys, Tehran, Iran
[5] Univ Tehran Med Sci, Sch Med, Dept Med Phys & Biomed Engn, Tehran, Iran
来源
关键词
Radiotherapy; Brain tumors; Hippocampus; NORMAL TISSUE; RADIATION; HEAD; EYE;
D O I
10.18869/acadpub.ijrr.19.2.333
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: Radiation therapy (RT) is one of the common and successful treatments for brain malignancies and benign disorders. In spite of its irrefutable merits, it is associated with a number of complications caused by radiation damage to the important Organs at Risks (OARs), which is strongly correlated with the radiation dose during RT. This study aimed to determine the range of radiation dose to Hippocampus and certain OARs in the brain. Materials and Methods: Thirty-two patients with primary brain cancer, undergoing RT, were selected retrospectively. The selected OARs were contoured using the RT Treatment Planning Software through assessing the images from the computed tomography and magnetic resonance imaging (MRI). Dose parameters, namely maximum dose (Dmax) and median dose (Dmedian), to OARs (optic nerves, chiasm, retinas, lenses, orbits, lachrymal glands, brainstem, hippocampi, etc.) were assessed. Results: The mean age of the patients was 37.8 +/- 14.3 years (from 5 to 60 years), and 19 patients (59%) were male. Glioblastoma multiforme and astrocytoma were the most common tumors. The maximum dose received by the brainstem, lenses, and eye ranged between 32-62 Gy, 0.75-40 Gy, 1.5-65 Gy, respectively. The maximum dose received by the hippocampi was 62.7 Gy. Conclusion: Important OARs can tolerate the received doses which were lower than the threshold level of serious complications. However, the maximum dose received by the hippocampi was higher than the recommended tolerated radiation dose; therefore, it is recommended to conduct more studies in this regard.
引用
收藏
页码:333 / 337
页数:5
相关论文
共 50 条
  • [1] Evaluation of Organs at Risk's Dose in External Radiotherapy of Brain Tumors
    Nazemi-Gelyan, Hamideh
    Hasanzadeh, Hadi
    Makhdumi, Yasha
    Abdollahi, Sara
    Akbari, Fatemeh
    Varshoee-Tabrizi, Fatemeh
    Almasrou, Hamzeh
    Nikoofar, Alireza
    Rezaei-Tavirani, Mostafa
    IRANIAN JOURNAL OF CANCER PREVENTION, 2015, 8 (01) : 47 - 52
  • [2] Evaluation of the dose received by organs at risk
    Mervoyer, A.
    Lisbonna, A.
    Rio, E.
    Mahe, M.
    CANCER RADIOTHERAPIE, 2010, 14 (4-5): : 232 - 235
  • [3] REDUCING DOSE TO ORGANS-AT-RISK IN RADIOTHERAPY OF BRAIN TUMORS ARISING IN POSTERIOR FOSSA
    Lee, Young K.
    Fiore, Maria R.
    Sanne, Chantal
    Mandeville, Henry C.
    Saran, Frank H.
    NEURO-ONCOLOGY, 2012, 14 : 146 - 146
  • [4] Evaluation of the organs at risk doses for lung tumors in gated and conventional radiotherapy
    Shahzadeh, Sara
    Gholami, Somayeh
    Mahmood, Seyed
    Aghamiri, Reza
    Mahani, Hojjat
    Nabavi, Mansoure
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 (04) : 726 - 730
  • [5] Neurocognition and mean radiotherapy dose to vulnerable brain structures: new organs at risk?
    Helena Söderström
    Angelica Walfridsson
    Ulla Martinsson
    Ulf Isacsson
    Karin Brocki
    Johan Lundin Kleberg
    Gustaf Ljungman
    Radiation Oncology, 18
  • [6] Neurocognition and mean radiotherapy dose to vulnerable brain structures: new organs at risk?
    Soderstrom, Helena
    Walfridsson, Angelica
    Martinsson, Ulla
    Isacsson, Ulf
    Brocki, Karin
    Kleberg, Johan Lundin
    Ljungman, Gustaf
    RADIATION ONCOLOGY, 2023, 18 (01)
  • [7] Assessment of Volume Dose to Organs at Risk in Radiation Therapy for brain Tumors at the Tomotherapy
    Wilhelm-Buchstab, T.
    Garbe, S.
    Luetter, C.
    Muedder, T.
    Logvinski, T.
    Schoroth, F.
    Schild, H. H.
    Schueller, H.
    Leitzen, C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 : 80 - 81
  • [8] RADIOTHERAPY IN THE TREATMENT OF NEUROBLASTOMA: EVALUATION OF DOSE RECEIVED BY HEALTHY ORGANS AROUND THE TARGET, DRAWN BEFORE AND AFTER SURGERY
    Vallerga, F.
    Torielli, P.
    Barra, S.
    Giannelli, F.
    Gusinu, M.
    Garaventa, A.
    Manzitti, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (07): : S13 - S14
  • [9] Specification of the dose to organs at risk in external beam radiotherapy
    Dale, E
    Olsen, DR
    ACTA ONCOLOGICA, 1997, 36 (02) : 129 - 135
  • [10] Whole brain radiotherapy: Are parotid glands organs at risk?
    Fiorentino, Alba
    Chiumento, Costanza
    Caivano, Rocchina
    Cozzolino, Mariella
    Clemente, Stefania
    Pedicini, Piernicola
    Fusco, Vincenzo
    RADIOTHERAPY AND ONCOLOGY, 2012, 103 (01) : 130 - 131